Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices

Journal of Controlled Release

Volumn 122, Issue 2, 2007, Pages 173-180

  Gbureck, Uwe ^a   Vorndran, Elke ^a   Müller, Frank A ^b   Barralet, Jake E ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Adsorption; Antibiotics; Calcium phosphate ceramics; Cement; Release profile

Indexed keywords

ADSORPTION; BIOCERAMICS; CORRELATION METHODS; IMPREGNATION; THERMAL EFFECTS;

BIOCOMPOSITES; CALCIUM PHOSPHATE CERAMICS; DRUG RELEASE; RELEASE PROFILES;

ANTIBIOTICS;

ANTIBIOTIC AGENT; BIOCERAMICS; CALCIUM PHOSPHATE DIBASIC; HYDROXYAPATITE; OFLOXACIN; PHOSPHATE BUFFERED SALINE; POLYGLYCOLIDE; POLYLACTIDE; POLYMER; TETRACYCLINE; VANCOMYCIN;

ARTICLE; COMPOSITE MATERIAL; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DESORPTION; DRUG ADSORPTION; IMMERSION; LINEAR SYSTEM; LOW TEMPERATURE; NONLINEAR SYSTEM; POROSITY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TIME; ULTRAVIOLET SPECTROPHOTOMETRY;

ADSORPTION; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG IMPLANTS; DURAPATITE; KINETICS; MODELS, CHEMICAL; OFLOXACIN; POLYESTERS; POLYGLYCOLIC ACID; POROSITY; POWDERS; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TETRACYCLINE; VANCOMYCIN;

EID: 34548404586     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.06.022     Document Type: Article

References (51)

1. Zitzmann N.U., Rateitschak-Pluss E., and Marinello C.P. Treatment of angular bone defects with a composite bone grafting material in combination with a collagen membrane. J. Periodontol. 74 (2003) 687-694
2. Ramshaw J.A.M., Werkmeister J.A., and Peters D.E. Collagen as a biomaterial. In: Williams D.F. (Ed). Current perspectives on implantable devices vol. 2 (1990), Jai Press Ltd., London 151-220
3. Vert M., Li S.M., Spenlehauer G., and Guerin P. Bioresorbability and biocompatibility of aliphatic polyesters. J. Mater. Sci., Mater. Med. 3 (1992) 432-446
4. Hench L.L., and Andersson Ö. Bioactive glasses. In: Hench L.L., and Wilson J. (Eds). An introduction to bioceramics (1993), World Scientific, Singapore
5. Kay J.F. Bioactive surface coatings for hard tissue biomaterials. CRC Handb. Bioact. Ceram. 2 (1990) 111-122
6. Schmitz J.P., Hollinger J.O., and Milam S.B. Reconstruction of bone using calcium phosphate bone cements: a critical review. J. Oral Maxillofac. Surg 57 (1999) 1122-1126
7. Ruchholtz S., Tager G., and Nast-Kolb D. The periprosthetic total hip infection. Unfallchirurg 107 (2004) 307-317
8. Costerton J.W. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin. Orthop. Relat. Res. (2005) 7-11
9. Bertazzoni Minelle E., Benini A., Magnan B., and Bertolozzi P. Release of gentamicin and vancomycin from temporary human hip spacer in two-stage revision of infected arthroplasty. J. Antimicrob. Chemother. 53 (2004) 329-334
10. Frutos Cabanillas P., Diez Peña E., Barrales-Rienda J.M., and Frutos G. Validation and in vitro characterization of antibiotic-loaded bone cement release. Int. J. Pharm. 209 (2000) 15-26
11. Torrado S., Frutos P., and Frutos G. Gentamicin bone cement: characterization and release (in vitro and in vivo assay). Int. J. Pharm. 217 (2001) 57-69
12. Joosten U., Joist A., Gosheger G., Liljenquist U., Brandt B., and von Eiff C. Effectivness of hydroxyapatite-vancomycin bone cement in the treatement of Staphyloccocus aureus induced chronic osteomyelitis. Biomaterials 26 (2005) 5251-5258
13. Rauschmann M.A., Wichelhaus T.A., Stirnal V., Dingeldein E., Zichner L., Schnettler R., and Alt V. Nanocristalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 26 (2005) 2677-2684
14. Dion A., Langmann M., Hall G., and Filiaggi M. Vancomycin release behavior from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment. Biomaterials 26 (2005) 7276-7285
15. Bohner M., Lemaître J., van Landuyt P., Zambelli P.Y., Merkle H.P., and Gander B. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery System. J. Pharm. Sci. 86 (1997) 565
16. Bohner M., Lemaitre J., Merkle H.P., and Gander B. Control of gentamicin release from a calcium phosphate cement by admixed poly(acrylic acid). J. Pharm. Sci. 89 (2000) 1262-1270
17. Ginebra M.P., Traykova T., and Planell J.A. Calcium phosphate cements as bone drug delivery systems: a review. J. Control Release 113 (2006) 102-110
18. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., and Higuchi W.I. A novel skeletal drug delivery system using self-setting calcium phosphate cement 5: drug-release behaviour from a heterogeneous drug-loaded cement containing an anticancer drug. J. Pharm. Sci. 83 (1994) 1565-1568
19. Otsuka M., Nakahigashi Y., Matsuda Y., Fox J.L., Higuchi W.I., and Sugiyama Y. A novel skeletal drug delivery system using self-setting calcium phosphate cement VIII: the relationship between in vitro and in vivo drug release from indomethacin-containing cement. J. Control. Release 43 (1997) 115-122
20. Otsuka M., Yoneoka K., Matsuda Y., Fox J.L., Higuchi W.I., and Sugiyama Y. Oestradiol release from self-setting apatitic bone cement responsive to plasma-calcium level in ovariectomized rats and its physicochemical mechanism. J. Pharm. Pharmacol. 49 (1997) 1182-1188
21. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., and Higuchi W.I. Novel skeletal drug-delivery system using self-setting calcium phosphate cement. 3. Physicochemical properties and drug-release rate of bovine insulin and bovine albumin. J. Pharm. Sci. 83 (1994) 255-258
22. U. Gbureck, T. Hölzel, R. Thull, F.A. Müller, J.E. Barralet, Preparation of nanocrystalline hydroxyapatite scaffolds by 3D powder printing. Cytotherapy 8 (2006) 14-14 046 Suppl. 2.
23. Gbureck U., Hölzel T., Doillon C., Müller F.A., and Barralet J.E. Direct printing of bioceramic implants with spatially localised angiogenic factors. Adv. Mater. 19 (2007) 795-800
24. Byrne R.S., and Deasy P.B. Use of commercial porous ceramic particles for sustained drug delivery. Int. J. Pharmaceutics 246 (2002) 61-73
25. Siepmann J., and Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 48 (2001) 139-157
26. Kosmidis K., Argyrakis P., and Macheras P. A reappraisal of drug release laws using Monte Carlo simulation: the prevalence of the Weibull function. Pharm. Res. 20 (2003) 988-995
27. Quieroz A., Santos J., Monteiro F., Gibson I., and Knowles J.C. Adsorption and release studies of sodium ampicillin from hydroxyapatite and glass reinforced hydroxyapatite composites. Biomaterials 22 (2001) 1393-1400
28. Slosarczyk A., Szymure-Oleksiak J., and Mycek M. The kinetics of pentoxifylline release from drug-loaded hydroxyapatite implants. Biomaterials 21 (2000) 1215-1221
29. Saito T., Takeuchi R., Hirakawa K., Nagata N., Yoshida T., Koshina T., Okuda K., Takema M., and Hori T. Slow-releasing potential of vancomycin-loaded porous hydroxyapatite blocks implanted into MRSA osteomyelitis. J. Biomed. Mater. Res. (Appl. Biomater.) 63 (2002) 245-251
30. Dion A., Berno B., Hall G., and Filiaggi M. The effect of processing on the structural characteristics of vancomycin-loaded amorphous calcium phosphate matrices. Biomaterials 26 (2005) 4486-4494
31. Akashi A., Matsuya Y., Unemori M., and Akamine A. Release profile of antimicrobial agents from a-tricalcium phosphate cement. Biomaterials 22 (2001) 2713-2717
32. Obadia L., Amador G., Daculsi G., and Bouler J.M. Calcium-deficient apatite: influence of granule size and consolidation mode on release and in vitro activity of vancomycin. Biomaterials 24 (2003) 1265-1270
33. Takechi M., Miyamoto Y., Momota Y., Yuasa T., Tatehara S., Nagayama M., Ishikawa K., and Suzuki K. The in vitro antibiotic release from anti-washout apatite cement using chitosan. J. Mater. Sci., Mater. Med. 13 (2002) 973-978
34. Hamanishi C., Kitamoto K., Tanaka S., Otsuka M., Doi Y., and Kitahashi T. A self-setting TTCP-DCPD apatite cement for release of vancomycin. J. Biomed. Mater. Res. 33 (1996) 139-143
35. Yu D., Wong J., Matsuda Y., Fox J., Higuchi W., and Otsuka M. Self-setting hydroxyapatite cement: a novel skeletal drug delivery system for antibiotics. J. Pharm. Sci. 81 (1992) 529-531
36. Ratier A., Gibson I.R., Best S.M., Freche M., Lacout J.L., and Rodriguez F. Setting characteristics and mechanical behaviour of a calcium phosphate bone cement containing tetracycline. Biomaterials 22 (2001) 897-901
37. Takechi M., Miyamoto Y., Ishikawa K., Nagayama M., Kon M., Asaoka K., and Suzuki K. Effects of added antibiotics on the basic properties of anti-washout-type fast setting calcium phosphate cement. J. Biomed. Mater. Res. 39 (1998) 308-316
38. U. Gbureck, T. Hölzel, U. Klammert, K. Würzler, F.A. Müller, J.E. Barralet, Resorbable dicalcium phosphate bone substitutes made by 3D powder printing. Adv. Func. Mat. in press.
39. Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Injury 31 (2000) 37-47
40. Grover L.M., Knowles J.C., Fleming G.J.P., and Barralet J.E. In vitro dissolution of Brushite cement. Biomaterials 24 (2003) 4133-4141
41. Rosseau S., Lemaitre J., Bohner M., and Frei C. Long term ageing of brushite cements in physiological conditions: An in vitro study (2002), GRIBOI, Shanghai
42. Constantz B.R., Barr B.M., Ison I.C., Fulmer M.T., Baker J., McKinney L., Goodman S.B., Gunasekaren S., Delaney D.C., Ross J., and Poser R.D. Histological, Chemical, and crystallographic analysis of four calcium phosphate cements in different rabbit osseus sites. J. Biomed. Mater. Res. 43 (1998) 451-461
43. Tadic D., Welzel T., Seidel P., Wüst E., Dingeldein E., and Epple M. Controlled release of gentamicin from biomimetic calcium phosphate in vitro. Comparison of four different incorporation methods. Mat.-wiss. u. Werkstofftech. 35 (2004) 1001-1005
44. Tongaree S., Flanagan D.R., and Poust R.I. The interaction between oxytetracycline and divalent metal ions in aqueous and mixed solvent systems. Pharm. Dev. Technol. 4 (1999) 581-591
45. Grover L.M., Knowles J.C., Fleming G.J.P., and Barralet J.E. In vitro ageing of brushite calcium phosphate cement. Biomaterials 24 (2003) 4133-4141
46. Castro C., Sánchez E., Delgado A., Soriano I., Núñez P., Baro M., Perera A., and Évora C. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. J. Control. Release 93 (2003) 341-354
47. Bonk U., and Frieden H. Gewebsverträglichkeit von Gentamycin-PMMA-Ketten und - Kugeln. Arch. Orthop. Trauma. Surg. 93 (1979) 241-242
48. Bittner B., Maeder K., Kroll C., Borchert H.H., and Kissel T. Tetracycline-HCl-loaded poly(dl-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation. J. Control. Release 59 (1999) 23-32
49. Gavini E., Chetoni P., Cossu M., Alvarez M.G., Saettone M.F., and Giunchedi P. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur. J. Pharm. Biopharm. 57 (2004) 207-212
50. Schnieders J., Gbureck U., Thull R., and Kissel T. Controlled release of gentamicin from calcium phosphate - poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 27 (2006) 4239-4249
51. Naraharisetti P.V., Lee H.C.G., Fu Y.C., Lee D.J., and Wang C.H. In vitro and in vivo release of gentamicin from biodegradable discs. J. Biomed. Mater. Res. Part B: Appl. Biomater. 77B (2006) 329-337